Coronary Artery Bypass Graft Market

Growing incidence of cardiovascular disease to propel market growth

The key driver of the rise in the global market for coronary artery bypass graft devices is the increase in cardiovascular disease cases, which is mostly related to conditions including obesity, diabetes, and high blood pressure. For instance, cardiovascular illness is one of the main causes of death worldwide, according to the WHO's 2021 factsheet. Almost 17.9 million people died from it in 2019, and 75 percent of cardiovascular disease deaths take place in low- and middle-income nations.

The demand for coronary artery bypass graft (CABG) devices has increased as a result of the development of new and improved CABG technologies, such as robotic-assisted systems. Furthermore, as the population ages, the prevalence of cardiovascular disease rises, creating a greater need for coronary artery bypass graft surgeries and the related equipment, leading to the expansion of the market for coronary artery bypass graft devices. Thus, this factor is driving the market CAGR.

Furthermore, to treat cardiovascular disorders, coronary artery bypass grafting (CABG) is being recommended for more older patients as the population ages. As octogenarians have the highest prevalence of coronary artery disease and are the fastest-growing cohort, cardiothoracic surgeons are increasingly being directed to them for surgical revascularization. The percentage of patients over 70 who underwent heart surgery grew from 11.2 to 36.7% in Germany between 1989 and 2000. The possibility of unsuccessful surgery is one of the issues with operating on older individuals. Patients who are older or who have frail tissue are worried that they won't heal as well.

The market will grow as a result of all of these particular elements.

However, the rise of the market is predicted to be fueled by favourable reimbursement policies for coronary artery bypass grafting across various countries. The need for differential cardiac surgery tariffs in Israel at the time of an ageing population and emerging technology: Importance of procedure type and patient complexity as assessed by EuroSCORE, according to a study published in the Israel Journal of Health Policy Research in September 2021, states that a surgery requiring only CABG will be reimbursed similarly to surgery requiring CABG and replacement of two valves.

Hence, all CABG procedures are compensated similarly to heart valve replacement procedures, and the existence of a suitable CABG reimbursement procedure is anticipated to promote market growth. Thus, it is anticipated that this aspect will accelerate coronary artery bypass graft market revenue globally.

The Global Coronary Artery Bypass Graft Market is projected to experience substantial growth over the next decade. By 2024, the market is expected to reach 13.3 USD Billion, with further expansion anticipated to 31.7 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 8.22% from 2025 to 2035. Such projections reflect the increasing demand for coronary artery bypass grafting procedures, driven by factors such as the aging population, rising prevalence of cardiovascular diseases, and advancements in surgical technologies. The market's robust growth is indicative of the critical role that coronary artery bypass grafting plays in modern cardiovascular care.

The increasing geriatric population worldwide is a crucial factor driving the Global Coronary Artery Bypass Graft Market Industry. Older adults are more susceptible to cardiovascular diseases due to age-related physiological changes and the accumulation of risk factors over time. As the global population ages, the demand for coronary artery bypass grafting is anticipated to rise significantly. This demographic shift necessitates healthcare systems to adapt and expand their cardiovascular care services. The market is expected to grow at a compound annual growth rate of 8.22% from 2025 to 2035, reflecting the urgent need for surgical interventions among the aging population.

An increase in healthcare expenditure across various regions is propelling the Global Coronary Artery Bypass Graft Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes advanced surgical facilities and technologies. This trend is particularly evident in developing countries, where improving healthcare access and quality is a priority. As healthcare budgets expand, more patients gain access to necessary surgical procedures, including coronary artery bypass grafting. This growing investment is likely to enhance the market's growth trajectory, supporting the projected increase in market value to 31.7 USD Billion by 2035.

Awareness and education initiatives regarding cardiovascular health are playing a pivotal role in the Global Coronary Artery Bypass Graft Market Industry. Public health campaigns aimed at educating individuals about the risks of cardiovascular diseases and the benefits of early intervention are becoming increasingly prevalent. These initiatives encourage individuals to seek medical advice and treatment sooner, leading to higher rates of diagnosis and subsequent surgical interventions. As awareness grows, so does the demand for coronary artery bypass grafting, thereby driving market growth. The emphasis on preventive care and education is expected to sustain the market's expansion in the coming years.

The rising incidence of cardiovascular diseases globally is a primary driver for the Global Coronary Artery Bypass Graft Market Industry. According to health statistics, cardiovascular diseases remain the leading cause of mortality worldwide, accounting for approximately 31% of all deaths. This alarming trend necessitates effective surgical interventions, such as coronary artery bypass grafting, to restore blood flow and improve patient outcomes. As the population ages and lifestyle-related risk factors proliferate, the demand for bypass surgeries is expected to surge, contributing to the market's growth. The Global Coronary Artery Bypass Graft Market is projected to reach 13.3 USD Billion by 2024, reflecting this urgent healthcare need.

Innovations in surgical techniques and technologies are significantly influencing the Global Coronary Artery Bypass Graft Market Industry. The advent of minimally invasive procedures, robotic-assisted surgeries, and advanced imaging technologies has enhanced the precision and safety of bypass grafting. These advancements not only reduce recovery times but also improve surgical outcomes, making the procedure more appealing to both patients and healthcare providers. As hospitals adopt these cutting-edge technologies, the market is likely to experience accelerated growth. The integration of such innovations is expected to contribute to the projected market value of 31.7 USD Billion by 2035, indicating a robust future for the Global Coronary Artery Bypass Graft Market.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America coronary artery bypass graft market accounted for USD 4.8 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period.

One of the main causes of the growth is the sharp increase in the prevalence of various cardiovascular conditions, including coronary artery disease, strokes, and atrial fibrillation, around the world as a result of the rise in lifestyle-related illnesses like diabetes and obesity, which increase the need for surgical grafts and devices.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: CORONARY ARTERY BYPASS GRAFT MARKET SHARE BY REGION 2023 (%)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe coronary artery bypass graft market accounts for the second-largest market share. Due to advancements in healthcare infrastructure, technologies, etc., which have provided access to high-quality care services at a reasonable price, it is one of the most developed places where CABG operation is offered. Moreover, people living longer lives are more prone to getting chronic illnesses like heart failure or coronary artery diseases. Further, the UK coronary artery bypass graft market held the largest market share, and the Germany coronary artery bypass graft market was the fastest growing market in the region.

Asia Pacific coronary artery bypass graft Market is expected to grow at the fastest CAGR from 2024 to 2030 due of the ageing population and rising cardiovascular disease prevalence. The number of surgeries will rise as a result, which may be ascribed to a number of causes like high disposable income, a developing healthcare industry, increasing public awareness of health issues as a result of cutting-edge marketing tactics used by major players, etc.

Moreover, China coronary artery bypass graft market held the largest market share, and the India coronary artery bypass graft market was the fastest growing market in the region.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the coronary artery bypass graft market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the coronary artery bypass graft industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the global coronary artery bypass graft industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, coronary artery bypass graft industry has provided medicine with some of the most significant benefits. The coronary artery bypass graft market major player such as Hancock Jaffe Laboratories, Inc., VasoPrep Surgical, Dextera Surgical Inc., Neograft Inc., Terumo Cardiovascular Systems Corporation, NOVADAQ Technologies Inc., MAQUET Holding B.V. & Co. KG., Genesee BioMedical, Sorin Group, Boston Scientific, Edwards Lifesciences Corporation and Others.

Formerly known as Red Line Thermometer Corporation, Terumo Corporation was established in 1921 to manufacture medical thermometers in Japan by a group of medical researchers under the direction of Dr. Kitasato Shibasabur. The company's first item was "Jintan Taionkei," the first thermometer created in Japan that could be purchased, and it has since developed into a maker of medical devices, putting out items for diabetic treatment, cardiovascular systems, and disposable medical equipment.

In April 2022, Terumo Corporation changed the name of the "General Hospital Company" to its brand-new name, "Medical Care Solutions Company." In order to achieve ongoing growth and work towards Terumo's 5-Year Growth Strategy, the Medical Care Solutions Company will simultaneously launch its innovative brand, "Terumo Medical Care Solutions (TMCS)," and reorganize its business (GS26). Currently, a paradigm shift is taking place in the healthcare scene.

A biomedical/biotechnology engineering company and global manufacturer of medical devices for interventional medical specialties such as interventional radiology, interventional cardiology, electrophysiology, vascular surgery, cardiac surgery, endoscopy, peripheral interventions, neuromodulation, neurovascular intervention, oncology, urology, and gynaecology, Boston Scientific Corporation ("BSC") was founded in Delaware. Boston Scientific is well-known for creating the Taxus Stent, a stent that releases drugs to clear blocked arteries.